Gastrointestinal

  • ALPHA AMYLASE 100MG + PAPAIN 100MG + SIMETHICONE 30MG

    Alpha Amylase is an enzyme which aids in the breakdown of starch to maltose. Alpha-amylase hydrolyzes bonds between glucose repeats.

    Papain is a cysteine hydrolase that catalyzes the breakdown of proteins by hydrolysis.

    Simethicone is an antiflatulent. It acts in the stomach and intestines to change the surface tension of gas bubbles, enabling their breakdown and the formation of larger bubbles, which makes gas easier to eliminate.

  • ALUMINA 250MG + MAGNESIA 250MG + SIMETHICONE 50MG/5ML

    Alumina is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions.

    Magnesia increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.

    Simethicone is an antiflatulent. It acts in the stomach and intestines to change the surface tension of gas bubbles, enabling their breakdown and the formation of larger bubbles, which makes gas easier to eliminate.

  • ESOMEPRAZOLE 40MG

    Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell.

  • ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE 20MG

    Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell.

  • RANITIDINE 300MG

    A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors).

  • DRIED ALUMINA HYDROXIDE 125MG + MAGNESIUM HYDROXIDE 200MG + LIDOCAINE HYDROCHLORIDE 12.5MG + MAGNESIUM TRISILICATE 125MG

    Alumina is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions.

    Magnesia increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.

    Lidocaine is an anesthetic agent that stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action.

  • MAGNESIUM TRISILICATE 250MG + ALUMINIUM HYDROXIDE 250MG + SIMETHICONE 25MG

    Magnesia increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.

    Alumina is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions.

    Simethicone is an antiflatulent. It acts in the stomach and intestines to change the surface tension of gas bubbles, enabling their breakdown and the formation of larger bubbles, which makes gas easier to eliminate.

  • RANITIDINE HYDROCHLORIDE 150MG + DOMPERIDONE 10MG

    Ranitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors).

    Domperidone is a peripheral dopamine-receptor blocker. It increases oesophageal peristalsis, lower oesophageal sphincter pressure, gastric motility and peristalsis, thus facilitating gastric emptying and decreasing small bowel transit time.

  • LANSOPRAZOLE 30MG + DOMPERIDONE 10MG

    Lansoprazole is a proton pump inhibitor which suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell.

    Domperidone is a peripheral dopamine-receptor blocker. It increases oesophageal peristalsis, lower oesophageal sphincter pressure, gastric motility and peristalsis, thus facilitating gastric emptying and decreasing small bowel transit time.

  • LANSOPRAZOLE 30MG

    Lansoprazole is a proton pump inhibitor which suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell.

  • RANITIDINE 150MG

    Ranitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors).

  • OMEPRAZOLE 20MG

    Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell.

  • RANITIDINE 150MG + DICYCLOMINE 10MG

    Ranitidine is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors).
    Dicyclomine is an anticholinergic drug that inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.

  • DOMPERIDONE 10MG + PANTOPRAZOLE 20MG

    Domperidone is a peripheral dopamine-receptor blocker. It increases oesophageal peristalsis, lower oesophageal sphincter pressure, gastric motility and peristalsis, thus facilitating gastric emptying and decreasing small bowel transit time.

  • PANTOPRAZOLE 40MG

    Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production by forming a covalent bond to two sites of the (H+,K+ )- ATPase enzyme system at the secretory surface of the gastric parietal cell.

  • LOPERAMIDE HYDROCHLORIDE 2MG

    A long-acting synthetic antidiarrheal, Loperamide acts by slowing intestinal motility and by affecting water and electrolyte movement through the bowel. Loperamide inhibits peristaltic activity by a direct effect on the circular and longitudinal muscles of the intestinal wall.